Metformin Hydrochloride Extended-Release Tablets, USP

Metformin hydrochloride extended-release tablets, USP, are a type of oral medication used in the management of type 2 diabetes mellitus. Metformin belongs to the class of drugs known as biguanides and is a widely prescribed first-line treatment for type 2 diabetes.

It works by lowering blood sugar levels primarily by decreasing the amount of glucose produced by the liver and increasing the sensitivity of muscle cells to insulin, allowing better uptake and use of glucose by the body’s cells.

The extended-release formulation of metformin provides a slow and consistent release of the medication throughout the day, allowing for once-daily dosing and potentially reducing gastrointestinal side effects compared to immediate-release formulations.